| Authors: |
Manjunatha L; Indo US Organization for Rare Diseases (IndoUSrare), Herndon, VA, 20171, USA., Ms S; Indo US Organization for Rare Diseases (IndoUSrare), Herndon, VA, 20171, USA., Dokuru D; Indo US Organization for Rare Diseases (IndoUSrare), Herndon, VA, 20171, USA., Venugopal N; Indo US Organization for Rare Diseases (IndoUSrare), Herndon, VA, 20171, USA., Waldrop JN; Rare Disease Diversity Coalition (RDDC), Black Women's Health Imperative (BWHI), Atlanta, GA, 3013, USA., Blount LG; Rare Disease Diversity Coalition (RDDC), Black Women's Health Imperative (BWHI), Atlanta, GA, 3013, USA., Kartha RV; Indo US Organization for Rare Diseases (IndoUSrare), Herndon, VA, 20171, USA.; Center for Orphan Drug Research, Department of Experimental and Clinical Pharmacology, University of Minnesota Twin Cities, Minneapolis, MN, USA., Rajasimha HK; Indo US Organization for Rare Diseases (IndoUSrare), Herndon, VA, 20171, USA. harshakarur@gmail.com.; Jeeva Clinical Trials, Inc, Manassas, VA, 20109, USA. harshakarur@gmail.com.; School of Systems Biology, George Mason University, Fairfax, VA, 22030, USA. harshakarur@gmail.com. |
